MSB 2.70% 95.0¢ mesoblast limited

Cell Therapy News/Articles, page-11041

  1. 15,520 Posts.
    lightbulb Created with Sketch. 5593
    I must admit it does astound me somewhat that the NIH and FDA 'appear' to be OK with these double year on year daily death numbers heading into the fall - the beginning of the worst / coldest period for the USA ?


    The FDA has also knocked back another EUA for COVID-19 this week (eg. Lenzilumab) and I am not seeing the moving of mountains like we have previously (say) 12-14 months ago ?


    With 177,433,044 people or 54% of the population fully vaccinated you would think both the FDA and NIH would be alarmed with the trajectory of the daily death numbers in comparison to September last year vs September this year - apparently not ?


    Florida and Texas with their numerous monoclonal antibody treatment centers are still sadly breaking records of daily death numbers and the Sept 2020 comparisons with Sept 2021 look bleak so surely this must concern some at these government agencies eventually ?


    Today
    upload_2021-9-11_11-59-54.png

    Yesterday
    upload_2021-9-11_11-59-22.png

    https://usafacts.org/visualizations/coronavirus-covid-19-spread-map/state/florida

    upload_2021-9-11_11-57-14.png

    https://usafacts.org/visualizations/coronavirus-covid-19-spread-map/state/texas

    upload_2021-9-11_11-58-45.png
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
95.0¢
Change
0.025(2.70%)
Mkt cap ! $1.084B
Open High Low Value Volume
94.0¢ 96.8¢ 93.5¢ $4.207M 4.417M

Buyers (Bids)

No. Vol. Price($)
3 42268 94.0¢
 

Sellers (Offers)

Price($) Vol. No.
95.0¢ 48002 3
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.